EC Number |
Substrates |
Organism |
Products |
Reversibility |
---|
2.7.11.15 | ATP + alpha2-adrenergic receptor |
- |
Bos taurus |
ADP + phospho-alpha2-adrenergic receptor |
- |
? |
2.7.11.15 | ATP + alpha2-adrenergic receptor |
dependent on agonist occupancy by (-)-epinephrine, equally effective as beta-adrenergic receptor, incorporation of 7-8 mol phosphate/mol receptor |
Bos taurus |
ADP + phospho-alpha2-adrenergic receptor |
- |
? |
2.7.11.15 | ATP + alpha2-adrenergic receptor |
agonist-induced phosphorylation |
Bos taurus |
ADP + phospho-alpha2-adrenergic receptor |
- |
? |
2.7.11.15 | ATP + alpha2-adrenergic receptor |
from human platelets |
Bos taurus |
ADP + phospho-alpha2-adrenergic receptor |
- |
? |
2.7.11.15 | ATP + alpha2A-adrenergic receptor |
- |
Bos taurus |
ADP + phosphorylated alpha2A-adrenergic receptor |
- |
? |
2.7.11.15 | ATP + alpha2A-adrenergic receptor |
interaction with GRK2 via the second and third intracellular loop of the receptor, determination of regions required for specific interaction and phosphorylation activity utilizing recombinant GST-tagged wild-type and several mutant alpha2A AR substrates, residues R225, R226, R218, K320, R322, and K358 are important, overview |
Bos taurus |
ADP + phosphorylated alpha2A-adrenergic receptor |
- |
? |
2.7.11.15 | ATP + beta-adrenergic receptor |
- |
Bos taurus |
ADP + phospho-beta-adrenergic receptor |
- |
? |
2.7.11.15 | ATP + beta-adrenergic receptor |
phosphorylation sites |
Bos taurus |
ADP + phospho-beta-adrenergic receptor |
- |
? |
2.7.11.15 | ATP + beta-adrenergic receptor |
phosphorylation sites are located mainly at the C-terminal tail of the receptor |
Bos taurus |
ADP + phospho-beta-adrenergic receptor |
- |
? |
2.7.11.15 | ATP + beta-adrenergic receptor |
incorporation of 7-8 mol phosphate/mol receptor |
Bos taurus |
ADP + phospho-beta-adrenergic receptor |
- |
? |